Skip to main content
Realcan Pharmaceutical Group Co.,Ltd. logo

Realcan Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 002589 ISIN · CNE1000013X5 LEI · 300300YI5IV3FBRRSJ48 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,678 across all filing types
Latest filing 2021-08-11 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002589

About Realcan Pharmaceutical Group Co.,Ltd.

https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. specializes in the distribution of pharmaceutical products, medical devices, and healthcare consumables. The company operates an extensive supply chain network, providing integrated logistics and distribution services primarily to medical institutions and healthcare providers. Its core operations include the procurement, storage, and delivery of a wide range of medical supplies, supported by advanced information management systems and cold-chain logistics capabilities. Realcan also offers value-added services such as hospital supply chain optimization, third-party logistics, and financial solutions tailored to the healthcare industry. By focusing on a direct-to-hospital distribution model, the company aims to enhance the efficiency of medical supply procurement and ensure the timely delivery of critical healthcare products.

Recent filings

Filing Released Lang Actions
第四届监事会第十四次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at the 14th meeting of the 4th Supervisory Board of Ruikang Pharmaceutical Group Co., Ltd. It includes details about approval of a guarantee limit proposal and a change in accounting policy related to new lease standards effective from January 1, 2021. The document is a formal announcement of board meeting decisions, not a full financial report or audit report. It does not contain financial statements or detailed financial analysis. It is also not a regulatory filing or certification letter. The content fits best with Board/Management Information (MANG) as it relates to internal governance decisions and management resolutions.
2021-08-11 Chinese
关于为控股及全资子公司提供担保进展情况的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from 瑞康医药集团股份有限公司 regarding the progress of guarantees provided by the company for its subsidiaries. It includes specific financial data about the guarantees, the companies involved, and their financial status. The document is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a call transcript, earnings release, or management report. It is a regulatory announcement about financing-related guarantees and collateral arrangements, which fits best under Capital/Financing Update (CAP). The document is substantive and over 8,000 characters, so it is not merely a report publication announcement or a short notice. Therefore, the classification is Capital/Financing Update (CAP).
2021-08-11 Chinese
关于实际控制人部分股份质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the pledge of shares by the actual controller of the company, including details about the number of shares pledged, pledge dates, and risks related to the pledge. It does not contain financial statements, audit information, or detailed financial results. It is a regulatory disclosure about share pledging, which is a capital-related event but not a financing update or share issuance. The document is short (1375 characters) and is a formal announcement of share pledge status by major shareholders. This fits best under Regulatory Filings (RNS) as it is a compliance disclosure about share pledging and related risks, not a full financial report or capital change announcement like SHA or CAP.
2021-08-06 Chinese
关于实际控制人部分股份解除质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the release of pledged shares by the company's actual controller. It details the number of shares released from pledge, the pledge start and release dates, and the current pledge status of shares held by major shareholders. There is no financial statement, earnings data, or management discussion. The document is short (1424 characters) and serves as a regulatory disclosure about share pledge status, which is a capital structure related update. This fits best under Capital/Financing Update (CAP) as it concerns financing activities related to share pledges and releases.
2021-07-16 Chinese
2020年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as an 'Annual Equity Distribution Implementation Announcement' for the year 2020 by 瑞康医药集团股份有限公司. It details the dividend distribution plan, including the amount per share, record date, ex-dividend date, and the method of dividend payment. It references the approval of the 2020 annual shareholders meeting and provides specifics on the dividend payout. The document is relatively short (2249 characters) and focuses solely on the announcement of the dividend distribution details rather than presenting a full annual report or financial statements. This matches the definition of a 'Notice of Dividend Amount' filing, which announces dividend amounts, payment dates, and details for shareholders. Therefore, the correct classification is DIV.
2021-06-16 Chinese
关于为控股及全资子公司提供担保进展情况的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from 瑞康医药集团股份有限公司 regarding the progress of guarantees provided for its holding and wholly-owned subsidiaries. It includes extensive tables listing guarantee amounts, relationships, financial institutions, guarantee types, and financial data of the guaranteed subsidiaries. The content focuses on the company's external guarantees, their amounts, and related financial conditions. There is no indication that this is a full financial report like an Annual Report (10-K) or Interim Report (IR). It is not a call transcript, earnings release, or management report. The document is a formal announcement about financing-related guarantees, which fits the category of Capital/Financing Update (CAP). The document length is substantial (over 14,000 characters), and it contains substantive financial data related to guarantees, not just a brief notice or certification. Therefore, the best classification is Capital/Financing Update (CAP).
2021-06-02 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.